winner
- Allena Pharmaceuticals, Inc. ALNA surged 64% to $0.1199. Allena Pharmaceuticals shares fell over 30% on Tuesday after the company announced it had filed for bankruptcy.
- Quoin Pharmaceuticals, Ltd. QNRX Shares rose 44.3% to $4.7893 after Alliance Global Partners began reporting on the stock with a buy rating and a price target of $20.
- IMARA Inc. IMRA Soared 37% to $1.57 after the company announced it had entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell Tovinontrin and other assets of its PDE9 program up front for $34.75 million.
- Sidus Space, Inc. SIDU Soared 26.7% to $3.3701 after the company announced it had signed a launch agreement with SpaceX for five launches beginning in early 2023.
- Cryo-Cell International, Inc. CCEL rose 17.7% to $7.86.
- bioAffinity Technologies, Inc. BIAF rose 19.7% to $6.45 after falling around 24% on Tuesday. The company last week priced its IPO at $6.125 per unit.
- Azure Power Global Limited AZRE Shares gained 17.3% to $4.21. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
- Pingtan Marine Enterprise Ltd. PME rose 17.3% to $0.8565.
- Glaukos Corporation GKOS up 17.3% to $56.40 after the Company announced topline data for both pivotal Phase 3 studies of iDose TR, which met their pre-specified primary efficacy endpoints over 3 months in both Phase 3 studies achieved and showed excellent tolerability and a favorable safety profile over 12 months.
- Aquestive Therapeutics, Inc. AQST rose 16.8% to $1.4599. Oppenheimer has commenced coverage of Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
- Spero Therapeutics, Inc. SPRO Shares rose 16.4% to $1.3150. Spero Therapeutics’ shares soared over 55% on Tuesday after the company received minutes of a Type A meeting with the FDA that discussed the steps needed to resubmit the regulatory application for Tebipenem HBr.
- Biophytis SA BPTS Stocks up 16% on…
